Bryant_Lab

Professor of Urology, Academic Consultant Urologist, Prostate Cancer Research. prior CRUK/RCSEng Clinician Scientist Fellow. RT not endorsement. views my own.

[Bryant_Lab @LabBryant]

Grateful to @BJUIjournal for publishing “The PRAGMATIC pathway ‐ PRostate cancer diAGnosis and MAnagement Triage In Clinical care”. Effective triaging steps for the highest risk suspected prostate cancer patients for rapid diagnosis & treatment https://t.co/EGpXjqUo7D

[Bryant_Lab @LabBryant]

@PART_Trial momentum. Grateful to all patients, & @NIHRresearch @NDSurgicalSci @SITU_Oxford & recruiting at Oxford, Edinburgh, Wexham Park, Reading, Coventry, Leeds, London (Imperial, UCL, Bart’s). Partial Ablation Vs Radical Tx for prostate cancer. @LondonProstate1 @mrsprostate

[PART_Trial @PART_Trial]

Thanks to @RBNHSFT for recruiting our 153rd participant to @PART_Trial we are 'halfway there' ‼️🥳also a HUGE thanks to all our PART sites, teams and participants 👏😊Let's keep going 💪#PAvsRT @LabBryant @SITU_Oxford @OCTRUctu @QuinteTBristol

[Bryant_Lab @LabBryant]

@LondonProstate1 @IP_London @bostonsci @SonablateCorp @mrsprostate @SGuillaumier @lucysimmons1 @johannboaz @FocalSociety @UkFocal @UKFUSFoundation @prost8uk @ProstateUKProfs The @NIHRresearch funded @PART_trial is robustly evaluating #focal therapy versus standard treatment options, recruiting in several UK centres not shown here. Level 1 evidence needed. @NDSurgicalSci @angiodynamics @FocalOneHIFU @SITU_Oxford

[Nuffield Department of Surgical Sciences @NDSurgicalSci]

A ground-breaking new study will test how artificial intelligence can make prostate cancer diagnosis more accurate. The study by the University of Oxford is funded by a £1.9m grant from research charity Prostate Cancer UK.

Read more ➡️ https://t.co/2NOBfWcrXY

[Bryant_Lab @LabBryant]

@VincentGnanapr3 @pash22 @ponganer @AlwynDart @LondonProstate1 @susan_bewley @MichaelBaum11 @naserturabi @mgtmccartney Other problems that need urgent focus are high rates of presentation with advanced disease, and health disparity, for Black & low socioeconomic & older men, varied access to molecular staging, & variable Active Surveillance. Screening risks of over-detection and over-treatment

[Bryant_Lab @LabBryant]

Tremendous effort @MarkarSheraz @SITU_Oxford @NDSurgicalSci @OCTRUctu !!! 👏

[SARONG OG @SARONG_Trial]

🎉SARONG just hit 800 participants! A huge THANK YOU to all the incredible research teams and especially to our amazing participants. We are so grateful for your support! #ResearchMilestone #ThankYou @MarkarSheraz @SITU_Oxford @OCTRUctu @NDSurgicalSci

[Bryant_Lab @LabBryant]

@Reddy4Urology presenting results of a multicentre evaluation of infield recurrence after #HIFU or #cryotherapy for #prostatecancer at therapy_focal in Washington, USA.

[Bryant_Lab @LabBryant]

Tremendous news - well done @NHSBartsHealth !! Looking forward to further recruited participants in this key @NIHRresearch funded RCT of #focaltherapy versus radical treatment for #prostatecancer from @SITU_Oxford @OCTRUctu @QuinteTBristol @LabBryant

[PART_Trial @PART_Trial]

...and they're off! @NHSBartsHealth have recruited their 1st participant to the PART_Trial 🥳Congrats to all involved 👏 @LabBryant @SITU_Oxford @OCTRUctu @QuinteTBristol

[Bryant_Lab @LabBryant]

Tremendous!! Many congratulations @MarkarSheraz Safe trip home, and it will be exciting to learn of your new collaborations and ideas for TransAtlantic Surgical Research!!!

[Sheraz Markar @MarkarSheraz]

Brilliant @AmCollSurgeons Congress in Chicago! So grateful to receive the international guest scholarship! Wonderful catching up with old and new friends. Brilliant to build stronger links between US UK for collaborative clinical trials. @NDSurgicalSci

[Bryant_Lab @LabBryant]

@IP_London @LondonProstate1 @BloombergUK The @PART_Trial in the UK, an RCT funded by @NIHRresearch and led from @OCTRUctu and @SITU_Oxford , is actively recruiting patients with intermediate-risk prostate cancer to robustly evaluate #FocalTherapy vs #RadicalTherapy. Level 1 evidence is needed - and we will deliver it.

[PART_Trial @PART_Trial]

The seasons may be changing but there's lots to celebrate - as #PART has just recruited it's 110th participant thanks to the @OUHospitals team 🥳@LabBryant @SITU_Oxford @OCTRUctu @QuinteTBristol

[PART_Trial @PART_Trial]

We've recently welcomed @nhsuhcw to #PART and they have already recruited their 1⃣st participant‼️Well done to all 🥳👏@LabBryant @SITU_Oxford @OCTRUctu @QuinteTBristol

[Bryant_Lab @LabBryant]

Thrilled to have been awarded full Professor of Urology at @NDSurgicalSci at @UniofOxford Huge thank you to all who have supported me - starting at @BryntegSixth to @sheffielduni then @UniofOxford - & especially @Freddie_Hamdy & my family & colleagues. #prostatecancer #research

[Bryant_Lab @LabBryant]

@sciqst @PART_Trial @NIHRresearch @SITU_Oxford @QuinteTBristol @OCTRUctu Thank you Dr Di Giacomo; @PART_Trial will assess oncological efficacy as #1 outcome; important #2 outcomes include side effects / treatment toxicity, QOL, health economics. No planned interim analyses. We plan to submit the protocol for publication soon, so please 👀

[Bryant_Lab @LabBryant]

A big day for the @PART_Trial 100 recruited participants, a significant way towards our required sample size, with the aim of delivering level 1 evidence for #focaltherapy versus #radicaltreatment for #prostatecancer @NIHRresearch @SITU_Oxford @QuinteTBristol @OCTRUctu

[PART_Trial @PART_Trial]

We did it!! #PART has recruited its 1⃣0⃣0⃣th participant at @FrimleyHealth 🥳 a massive thank you and to all our #PARTsites for your hard work getting us there!!!👏we are a step closer to answering our important question 👍@LabBryant @SITU_Oxford @OCTRUctu @QuinteTBristol

[Bryant_Lab @LabBryant]

@Lara__Rodriguez @LondonProstate1 @SIU_Journal @FocalSociety @IMMontsouris Nice review - but no mention of the fact there are several important ongoing RCTs recruiting patients with #prostatecancer comparing #focaltherapy vs radical treatment e.g. FARP, PRIS and @PART_Trial - to provide level 1 evidence.

[Bryant_Lab @LabBryant]

@CardiffCityFC Unreasonable for @CardiffCityFC to make it mandatory to have bought a Port Vale ticket for 2025-26 (which I can’t get to) to be eligible for Luton away; I went to over a dozen away last season and have a season ticket.

[PART_Trial @PART_Trial]

📢Big shoutout to @LeedsHospitals for recruiting their 1⃣st patient to PART 🎉@LabBryant @SITU_Oxford @NDSurgicalSci @QuinteTBristol

[Milos Grujic @grujicmilos10]

🚨 Just published in @TheLancetOncol!
📌 The #TRANSLATEtrial shows that LATP biopsy detects more clinically significant prostate cancer than TRUS (60.1% vs 54.4%; OR 1.32, p=0.031).
🧬 Lower infection risk
📊 Comparable complications
😖 Slightly more pain reported

🔗 https://t.co/LZGokyjWfi
📸 See infographic below 👇

@TranslateTrial @LambAlastair @HideYamaUrol @mercaderclaudia @Mutieraslan @CTBerridge @JessWhitburn @DrBenEddy @sashi_kommu
#ProstateCancer #UroOncology #OncoTwitter

[Declan Murphy @declangmurphy]

GU Cast celebrates these two excellent clinical trials run in the @NHS supported by @NIHRresearch, both presented in plenary #EAU25, both published @TheLancetOncol @TranslateTrial @neurosafeproof 😀👏 @RenuEapen @BAUSurology